(Q46272004)

English

Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial

scientific article published on 31 October 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18974967

Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial (English)

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18974967

diabetic nephropathy

1 reference

based on heuristic

inferred from title

Frederik Persson

3

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18974967

author name string

K J Schjoedt

1

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18974967

A S Astrup

2

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18974967

E Frandsen

4

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18974967

F Boomsma

5

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18974967

K Rossing

6

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18974967

L Tarnow

7

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18974967

P Rossing

8

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18974967

H-H Parving

9

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18974967

publication date

31 October 2008

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18974967

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18974967

52

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18974967

1

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18974967

46-49

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18974967

https://scigraph.springernature.com/pub.10.1007/s00125-008-1184-8

0 references

Lisinopril: dose-peak effect relationship in essential hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00125-008-1184-8

21 January 2018

Lisinopril dose-response relationship in essential hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00125-008-1184-8

21 January 2018

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1007%2FS00125-008-1184-8

21 January 2018

Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18974967

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18974967

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18974967

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual renin-angiotensin system blockade at optimal doses for proteinuria

1 reference

https://pubmed.ncbi.nlm.nih.gov/18974967

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Telmisartan, ramipril, or both in patients at high risk for vascular events

1 reference

https://pubmed.ncbi.nlm.nih.gov/18974967

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria

1 reference

https://pubmed.ncbi.nlm.nih.gov/18974967

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-008-1184-8

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18974967

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18974967

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46272004&oldid=2102606236"